需申請審核

Brain-Tumor-Progression

This collection includes datasets from 20 subjects with primary newly diagnosed glioblastoma who were treated with surgery and standard concomitant chemo-radiation therapy (CRT) followed by adjuvant chemotherapy. Two MRI exams are included for each patient: within 90 days following CRT completion and at progression (determined clinically, and based on a combination of clinical performance and/or imaging findings, and punctuated by a change in treatment or intervention). All image sets are in DICOM format and contain T1w (pre and post-contrast agent), FLAIR, T2w, ADC, normalized cerebral blood flow, normalized relative cerebral blood volume, standardized relative cerebral blood volume, and binary tumor masks (generated using T1w images). The perfusion images were generated from dynamic susceptibility contrast (GRE-EPI DSC) imaging following a preload of contrast agent. All of the series are co-registered with the T1+C images. The intent of this dataset is for assessing deep learning algorithm performance to predict tumor progression.

資料與資源

此資料集沒有資料

額外的資訊

欄位
最後更新 十二月 3, 2019, 14:28 (CST)
建立 二月 14, 2019, 10:19 (CST)

推薦資料集:


  • 上櫃股票除權除息計算結果表

    付費方式 免費
    更新頻率 不定期
    上櫃股票除權除息計算結果表(櫃買中心)
  • 全國育成中心資訊

    付費方式 免費
    更新頻率 不定期
    全國育成中心聯絡資訊
  • 2613-01-14-2 臺中市使用牌照稅查徵統計-以前年度

    付費方式 免費
    更新頻率 不定期
    臺中市使用牌照稅查徵統計-以前年度
  • 「四大新興智慧型產業」執行進度報告

    付費方式 免費
    更新頻率 不定期
    說明政府推動四大新興智慧型計畫之成果
  • 科技部文學二學門專題計畫補助清冊

    付費方式 免費
    更新頻率 不定期
    科技部文學二學門專題計畫補助清冊